i-SENS, Inc. (KOSDAQ:099190)
South Korea · Delayed Price · Currency is KRW 16,730
-90 (-0.54%)
At close: Dec 5, 2025
i-SENS Market Cap
i-SENS has a market cap or net worth of 461.51 billion as of December 5, 2025. Its market cap has decreased by -8.74% in one year.
Market Cap
461.51B
Enterprise Value
566.71B
Revenue
313.10B
Ranking
n/a
PE Ratio
666.71
Stock Price
16,730.00
Market Cap Chart
Since January 30, 2013, i-SENS's market cap has increased from 232.76B to 461.51B, an increase of 98.28%. That is a compound annual growth rate of 5.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 461.51B | 9.36% |
| Dec 30, 2024 | 422.03B | -46.36% |
| Dec 28, 2023 | 786.74B | 74.15% |
| Dec 29, 2022 | 451.77B | 9.85% |
| Dec 30, 2021 | 411.25B | 0.83% |
| Dec 30, 2020 | 407.85B | 16.73% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 77.77T |
| Celltrion | 39.95T |
| ALTEOGEN | 27.76T |
| ABL Bio | 11.08T |
| SK Biopharmaceuticals | 10.67T |
| Yuhan | 8.84T |
| LigaChem Biosciences | 7.14T |
| Peptron | 6.54T |